Alteration in serum concentrations of FGF19, FGF21, and FGF23 in patients with urothelial carcinoma

ABSTRACT Fibroblast growth factors (FGF) 19, 21, and 23 have been reported as functional factors in human metabolic diseases and malignancies. We performed a prospective survey to compare circulating FGF levels in urothelial carcinoma (UC) patients and normal controls. Between 2016 and 2017, 39 pati...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	BioFactors (Oxford) 2019-01, Vol.45 (1), p.62-68
Hauptverfasser:	Li, Jian‐Ri, Chiu, Kun‐Yuan, Ou, Yen‐Chuan, Wang, Shian‐Shiang, Chen, Chuan‐Su, Yang, Cheng‐Kuang, Ho, Hao‐Chung, Cheng, Chen‐Li, Yang, Chi‐Rei, Chen, Cheng‐Che, Wang, Shu‐Chi, Lin, Chia‐Yen, Hung, Sheng‐Chun, Hsu, Chiann‐Yi, Chen, Chun‐Jung
Format:	Artikel
Sprache:	eng
Schlagworte:	end‐stage renal disease fibroblast growth factor urothelial carcinoma
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!